Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-021612
Filing Date
2022-02-14
Accepted
2022-02-14 08:01:34
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G tm222623d2_sc13g.htm SC 13G 51305
  Complete submission text file 0001104659-22-021612.txt   52885
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

EIN.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 22625363
SIC: 2834 Pharmaceutical Preparations